Companion Diagnostics (CDx) Development Market Outlook: Increasing Adoption of Biomarker-Based Diagnostics
The advancement of precision medicine has transformed the healthcare industry by enabling treatments tailored to individual patient characteristics. Technologies such as molecular diagnostics, predictive biomarker testing, and in vitro companion diagnostics are becoming essential tools for identifying disease mechanisms, predicting treatment responses, and improving therapeutic outcomes. These...
0 Reacties 0 aandelen 47 Views 0 voorbeeld
Sponsor